Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophilic airway inflammation

Journal of Immunology

Volumn 186, Issue 10, 2011, Pages 5975-5982

  Nakagome, Kazuyuki ^a   Imamura, Mitsuru ^b   Okada, Hirokazu ^a   Kawahata, Kimito ^b   Inoue, Tsutomu ^a   Hashimoto, Kumiko ^a   Harada, Hiroaki ^b   Higashi, Takehiro ^a   Takagi, Rie ^a   Nakano, Kazuhisa ^a   Hagiwara, Koichi ^a   Kanazawa, Minoru ^a   Dohi, Makoto ^b   Nagata, Makoto ^a   Matsushita, Sho ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; GLYCOPROTEIN P 15095; INTERLEUKIN 17; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; OVALBUMIN; PHOSPHATE BUFFERED SALINE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; ASTHMA; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; FEMALE; FOXP3+ REGULATORY T LYMPHOCYTE; IMMUNOREGULATION; LUNG INFILTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT INFLAMMATION; TH17 CELL; TRANSGENIC MOUSE;

ANIMALS; BENZAZEPINES; BRONCHOALVEOLAR LAVAGE FLUID; DOPAMINE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; INFLAMMATION; INTERLEUKIN-23; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NEUTROPHILS; OVALBUMIN; RECEPTORS, DOPAMINE D1; RESPIRATORY HYPERSENSITIVITY; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 79956194050     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001274     Document Type: Article

References (57)

1. Bochner, B. S., B. J. Undem, and L. M. Lichtenstein. 1994. Immunological aspects of allergic asthma. Annu. Rev. Immunol. 12: 295-335.
2. Randolph, D. A., R. Stephens, C. J. Carruthers, and D. D. Chaplin. 1999. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J. Clin. Invest. 104: 1021-1029.
3. Randolph, D. A., C. J. Carruthers, S. J. Szabo, K. M. Murphy, and D. D. Chaplin. 1999. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J. Immunol. 162: 2375-2383.
4. McKinley, L., J. F. Alcorn, A. Peterson, R. B. Dupont, S. Kapadia, A. Logar, A. Henry, C. G. Irvin, J. D. Piganelli, A. Ray, and J. K. Kolls. 2008. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181: 4089-4097.
5. Lindén, A. 2001. Role of interleukin-17 and the neutrophil in asthma. Int. Arch. Allergy Immunol. 126: 179-184.
6. European Network for Understanding Mechanisms of Severe Asthma. 2003. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur. Respir. J. 22: 470-477.
7. Barczyk, A., W. Pierzchala, and E. Sozañska. 2003. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 97: 726-733.
8. Al-Ramli, W., D. Préfontaine, F. Chouiali, J. G. Martin, R. Olivenstein, C. Lemière, and Q. Hamid. 2009. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J. Allergy Clin. Immunol. 123: 1185-1187.
9. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
10. Murphy, K. M., W. Ouyang, J. D. Farrar, J. Yang, S. Ranganath, H. Asnagli, M. Afkarian, and T. L. Murphy. 2000. Signaling and transcription in T helper development. Annu. Rev. Immunol. 18: 451-494.
11. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
12. Lambrecht, B. N., and H. Hammad. 2003. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat. Rev. Immunol. 3: 994-1003.
13. + dendritic cells during allergen challenge abrogates the characteristic features of asthma. J. Exp. Med. 201: 981-991.
14. Nakano, K., T. Higashi, K. Hashimoto, R. Takagi, Y. Tanaka, and S. Matsushita. 2008. Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem. Biophys. Res. Commun. 373: 286-291.
15. Nakano, K., T. Higashi, R. Takagi, K. Hashimoto, Y. Tanaka, and S. Matsushita. 2009. Dopamine released by dendritic cells polarizes Th2 differentiation. Int. Immunol. 21: 645-654.
16. Missale, C., S. R. Nash, S. W. Robinson, M. Jaber, and M. G. Caron. 1998. Dopamine receptors: from structure to function. Physiol. Rev. 78: 189-225.
17. Hashimoto, K., T. Inoue, T. Higashi, S. Takei, T. Awata, S. Katayama, R. Takagi, H. Okada, and S. Matsushita. 2009. Dopamine D1-like receptor antagonist, SCH23390, exhibits a preventive effect on diabetes mellitus that occurs naturally in NOD mice. Biochem. Biophys. Res. Commun. 383: 460-463.
18. Okada, H., T. Inoue, K. Hashimoto, H. Suzuki, and S. Matsushita. 2009. D1-like receptor antagonist inhibits IL-17 expression and attenuates crescent formation in nephrotoxic serum nephritis. Am. J. Nephrol. 30: 274-279.
19. Knott, P. G., P. R. Gater, and C. P. Bertrand. 2000. Airway inflammation driven by antigen-specific resident lung CD4(+) T cells in alphabeta-T cell receptor transgenic mice. Am. J. Respir. Crit. Care Med. 161: 1340-1348.
20. Wilder, J. A., D. D. Collie, D. E. Bice, Y. Tesfaigzi, C. R. Lyons, and M. F. Lipscomb. 2001. Ovalbumin aerosols induce airway hyperreactivity in naïve DO11.10 T cell receptor transgenic mice without pulmonary eosinophilia or OVA-specific antibody. J. Leukoc. Biol. 69: 538-547.
21. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387. (Pubitemid 35279557)
22. Nakae, S., H. Suto, G. J. Berry, and S. J. Galli. 2007. Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood 109: 3640-3648.
23. Nakagome, K., M. Dohi, K. Okunishi, Y. Komagata, K. Nagatani, R. Tanaka, J. Miyazaki, and K. Yamamoto. 2005. In vivo IL-10 gene delivery suppresses airway eosinophilia and hyperreactivity by down-regulating APC functions and migration without impairing the antigen-specific systemic immune response in a mouse model of allergic airway inflammation. J. Immunol. 174: 6955-6966.
24. Nakagome, K., M. Dohi, K. Okunishi, R. Tanaka, T. Kouro, M. R. Kano, K. Miyazono, J. Miyazaki, K. Takatsu, and K. Yamamoto. 2007. IL-5-induced hypereosinophilia suppresses the antigen-induced immune response via a TGFβ-dependent mechanism. J. Immunol. 179: 284-294. (Pubitemid 46986544)
25. Nakagome, K., K. Okunishi, M. Imamura, H. Harada, T. Matsumoto, R. Tanaka, J. Miyazaki, K. Yamamoto, and M. Dohi. 2009. IFN-γ attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine. J. Immunol. 183: 209-220.
26. Okunishi, K., M. Dohi, K. Nakagome, R. Tanaka, S. Mizuno, K. Matsumoto, J. Miyazaki, T. Nakamura, and K. Yamamoto. 2005. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J. Immunol. 175: 4745-4753. (Pubitemid 41362016)
27. Nakagome, K., M. Dohi, K. Okunishi, R. Tanaka, J. Miyazaki, and K. Yamamoto. 2006. In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-β in the lung. Thorax 61: 886-894.
28. To, Y., M. Dohi, R. Tanaka, A. Sato, K. Nakagome, and K. Yamamoto. 2001. Early interleukin 4-dependent response can induce airway hyperreactivity before development of airway inflammation in a mouse model of asthma. Lab. Invest. 81: 1385-1396.
29. Hyllbrant, B., N. Tyrefors, K. E. Markides, and B. Långström. 1999. On the use of liquid chromatography with radio- and ultraviolet absorbance detection coupled to mass spectrometry for improved sensitivity and selectivity in determination of specific radioactivity of radiopharmaceuticals. J. Pharm. Biomed. Anal. 20: 493-501.
30. Takagi, R., T. Higashi, K. Hashimoto, K. Nakano, Y. Mizuno, Y. Okazaki, and S. Matsushita. 2008. B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones. J. Immunol. 181: 186-189.
31. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
32. Zou, W. 2006. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6: 295-307.
33. Aggarwal, S., N. Ghilardi, M. H. Xie, F. J. de Sauvage, and A. L. Gurney. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278: 1910-1914.
34. Bergquist, J., A. Tarkowski, R. Ekman, and A. Ewing. 1994. Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc. Natl. Acad. Sci. USA 91: 12912-12916.
35. Josefsson, E., J. Bergquist, R. Ekman, and A. Tarkowski. 1996. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 88: 140-146. (Pubitemid 26166387)
36. Ghosh, M. C., A. C. Mondal, S. Basu, S. Banerjee, J. Majumder D. Bhattacharya, and P. S. Dasgupta. 2003. Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells. Int. Immunopharmacol. 3: 1019-1026. (Pubitemid 36694872)
37. Saha, B., A. C. Mondal, S. Basu, and P. S. Dasgupta. 2001. Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis. Int. Immunopharmacol. 1: 1363-1374.
38. Carr, L., A. Tucker, and R. Fernandez-Botran. 2003. In vivo administration of L-dopa or dopamine decreases the number of splenic IFN γ-producing cells. J. Neuroimmunol. 137: 87-93.
39. Tsao, C. W., Y. S. Lin, and J. T. Cheng. 1997. Effect of dopamine on immune cell proliferation in mice. Life Sci. 61: 361-371.
40. Besser, M. J., Y. Ganor, and M. Levite. 2005. Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both. J. Neuroimmunol. 169: 161-171. (Pubitemid 41528789)
41. Meredith, E. J., A. Chamba, M. J. Holder, N. M. Barnes, and J. Gordon. 2005. Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology 115: 289-295. (Pubitemid 40896027)
42. Bergquist, J., A. Tarkowski, A. Ewing, and R. Ekman. 1998. Catecholaminergic suppression of immunocompetent cells. Immunol. Today 19: 562-567. (Pubitemid 28557119)
43. McKenna, F., P. J. McLaughlin, B. J. Lewis, G. C. Sibbring, J. A. Cummerson, D. Bowen-Jones, and R. J. Moots. 2002. Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J. Neuroimmunol. 132: 34-40.
44. Ricci, A., E. Bronzetti, F. Mignini, S. K. Tayebati, D. Zaccheo, and F. Amenta. 1999. Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes. J. Neuroimmunol. 96: 234-240. (Pubitemid 29234498)
45. Ricci, A., and F. Amenta. 1994. Dopamine D5 receptors in human peripheral blood lymphocytes: a radioligand binding study. J. Neuroimmunol. 53: 1-7.
46. + regulatory T-cell activity: implications for neurodegeneration. J. Neurosci. 24: 6133-6143.
47. Lin, Y. S., Q. Gu, and L. Y. Lee. 2003. Activation of dopamine D2-like receptors attenuates pulmonary C-fiber hypersensitivity in rats. Am. J. Respir. Crit. Care Med. 167: 1096-1101.
48. Helms, M. N., X. J. Chen, S. Ramosevac, D. C. Eaton, and L. Jain. 2006. Dopamine regulation of amiloride-sensitive sodium channels in lung cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L710-L722.
49. Helms, M. N., J. Self, H. F. Bao, L. C. Job, L. Jain, and D. C. Eaton. 2006. Dopamine activates amiloride-sensitive sodium channels in alveolar type I cells in lung slice preparations. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L610-L618.
50. Antonini, A., and P. Barone. 2008. Dopamine agonist-based strategies in the treatment of Parkinson's disease. Neurol. Sci. 29(Suppl 5): S371-S374.
51. Ilani, T., D. Ben-Shachar, R. D. Strous, M. Mazor, A. Sheinkman, M. Kotler, and S. Fuchs. 2001. A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc. Natl. Acad. Sci. USA 98: 625-628.
52. Kwak, Y. T., M. S. Koo, C. H. Choi, and I. Sunwoo. 2001. Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients. BMC Med. Genet. 2: 3.
53. Barbanti, P., G. Fabbrini, A. Ricci, G. Bruno, R. Cerbo, E. Bronzetti, F. Amenta, and G. Luigi Lenzi. 2000. Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease. Mech. Ageing Dev. 120: 65-75.
54. Barbanti, P., G. Fabbrini, A. Ricci, R. Cerbo, E. Bronzetti, B. Caronti C. Calderaro, L. Felici, F. Stocchi, G. Meco, et al. 1999. Increased expression of dopamine receptors on lymphocytes in Parkinson's disease. Mov. Disord. 14: 764-771.
55. Barbanti, P., G. Fabbrini, A. Ricci, M. P. Pascali, E. Bronzetti, F. Amenta, G. L. Lenzi, and R. Cerbo. 2000. Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes. Cephalalgia 20: 15-19. (Pubitemid 32250289)
56. Hietala, J., T. Seppäla, J. Lappalainen, and E. Syvälahti. 1992. Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood. Psychopharmacology (Berl.) 106: 455-458.
57. Monsma, F. J., Jr., L. C. Mahan, L. D. McVittie, C. R. Gerfen, and D. R. Sibley. 1990. Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc. Natl. Acad. Sci. USA 87: 6723-6727.